Assessing Variant Causality and Severity Using Retinal Pigment Epithelial Cells Derived from Stargardt Disease Patients
Authors:
Open Access
- 2 March 2022
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Translational Vision Science & Technology
- Vol. 11 (3) , 33
Abstract
Purpose: Modern molecular genetics has revolutionized gene discovery, genetic diagnoses, and precision medicine yet many patients remain unable to benefit from these advances as disease-causing variants remain elusive for up to half of Mendelian genetic disorders. Patient-derived induced pluripotent stem (iPS) cells and transcriptomics were used to identify the fate of unsolved ABCA4 alleles in patients with Stargardt disease. Methods: Multiple independent iPS lines were generated from skin biopsies of three patients with Stargardt disease harboring a single identified pathogenic ABCA4 variant. Derived retinal pigment epithelial cells (dRPE) from a normal control and patient cells were subjected to RNA-Seq on the Novaseq6000 platform, analyzed using DESeq2 with calculation of allele specific imbalance from the pathogenic or a known linked variant. Protein analysis was performed using the automated Simple Western system. Results: Nine dRPE samples were generated, with transcriptome analysis on eight. Allele-specific expression indicated normal transcripts expressed from splice variants albeit at low levels, and missense transcripts expressed at near-normal levels. Corresponding protein was not easily detected. Patient phenotype correlation indicated missense variants expressed at high levels have more deleterious outcomes. Transcriptome analysis suggests mitochondrial membrane biodynamics and the unfolded protein response pathway may be relevant in Stargardt disease. Conclusions: Patient-specific iPS-derived RPE cells set the stage to assess non-expressing variants in difficult-to-detect genomic regions using easily biopsied tissue. Translational Relevance: This “Disease in a Dish” approach is likely to enhance the ability of patients to participate in and benefit from clinical trials while providing insights into perturbations in RPE biology.Keywords
This publication has 37 references indexed in Scilit:
- Patient-specific iPSC-derived photoreceptor precursor cells as a means to investigate retinitis pigmentosaeLife, 2013
- Non-exomic and synonymous variants in ABCA4 are an important cause of Stargardt diseaseHuman Molecular Genetics, 2013
- Rapid and Efficient Directed Differentiation of Human Pluripotent Stem Cells Into Retinal Pigmented EpitheliumStem Cells Translational Medicine, 2013
- Induction of Retinal Pigment Epithelial Cells from Monkey iPS CellsInvestigative Ophthalmology & Visual Science, 2011
- Optic Vesicle-like Structures Derived from Human Pluripotent Stem Cells Facilitate a Customized Approach to Retinal Disease TreatmentStem Cells, 2011
- Complement System Dysregulation and Inflammation in the Retinal Pigment Epithelium of a Mouse Model for Stargardt Macular DegenerationJournal of Biological Chemistry, 2011
- Light exposure stimulates formation of A2E oxiranes in a mouse model of Stargardt's macular degenerationProceedings of the National Academy of Sciences, 2004
- Biochemical defects in ABCR protein variants associated with human retinopathiesNature Genetics, 2000
- The 220-kDa Rim Protein of Retinal Rod Outer Segments Is a Member of the ABC Transporter SuperfamilyJournal of Biological Chemistry, 1997
- A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Starqardt macular dystrophyNature Genetics, 1997